Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ucMSC Therapy for Non-viral ACLF
NCT07075315Phase 3Not yet recruiting
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jan 2028
- Primary completion
- Dec 2031
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of human umbilical cord mesenchymal stem cells in acute-on-chronic liver failure (ACLF), sponsored by Institute of Liver and Biliary Sciences. Planned start Jan 2028; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on NCT07075315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07075315.